European Journal of Dentistry · 2020 · 77 citations · 29 references
Life SciencesInfectious DiseasesMicrobiologyMedical MicrobiologyMolecular VirologyVirologyPoint-of-care Salivary TestingSaliva CollectionSalivary BiomarkersSalivary MicrobiologySaliva BiosensingSaliva DiagnosticsSaliva Specimen CollectionSaliva-based DiagnosticsSaliva-based ScreeningSalivary Gland Infection DiagnosisSalivary Infectious Disease TestingSevere Acute Respiratory Syndrome
Novel coronavirus disease 2019 (COVID-19) outbreak has termed as a controllable pandemic, and the entire world has come to a standstill trying to mitigate the disease with health systems. Health care providers, around the globe, are fighting day and night. Currently, rapid testing is taking place with the help of nasopharyngeal, oropharyngeal swab, bronchoalveolar lavage, sputum, urine, and blood. All these approaches are invasive or embarrassing to the infected person. It is observed that salivary glands are hosting severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) because of angiotensin-converting enzyme 2 and the detection of high viral loads in the saliva and is playing a crucial role in virus transmission, especially from individuals showing absolutely no symptoms. Saliva is proving to be a promising noninvasive sample specimen for the diagnosis of COVID-19, thus helping to monitor the infection and prevent it from further spreading by prompt isolation.
29
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Inge Hamming, Wim Timens, MLC Bulthuis et al. · The Journal of Pathology · 2004 · 5.9K citations · Full text
Veterinary Medicine, Infectious Diseases, Molecular Biology +11